Financial Metrics Check: Xeris Biopharma Holdings Inc (XERS)’s Ratios for Trailing Twelve Months

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.01 million shares were traded. XERS stock price reached its highest trading level at $3.31 during the session, while it also had its lowest trading level at $3.19.

Ratios:

To gain a deeper understanding of XERS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 2.26.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on March 28, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.

On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.

On October 21, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $4.Jefferies initiated its Buy rating on October 21, 2022, with a $4 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Schmid John P. bought 4,515 shares for $2.25 per share. The transaction valued at 10,147 led to the insider holds 25,200 shares of the business.

Schmid John P. bought 4,285 shares of XERS for $10,134 on Aug 09 ’24. The Director now owns 20,685 shares after completing the transaction at $2.37 per share. On May 10 ’24, another insider, Schmid John P., who serves as the Director of the company, bought 5,400 shares for $1.91 each. As a result, the insider paid 10,314 and bolstered with 16,400 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 482755808 and an Enterprise Value of 673502208. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.65. Its current Enterprise Value per Revenue stands at 3.713 whereas that against EBITDA is -26.941.

Stock Price History:

Over the past 52 weeks, XERS has reached a high of $3.39, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is 11.46%, while the 200-Day Moving Average is calculated to be 31.80%.

Shares Statistics:

It appears that XERS traded 1.52M shares on average per day over the past three months and 1196950 shares per day over the past ten days. A total of 138.13M shares are outstanding, with a floating share count of 136.46M. Insiders hold about 8.42% of the company’s shares, while institutions hold 38.27% stake in the company. Shares short for XERS as of 1728950400 were 11565005 with a Short Ratio of 7.58, compared to 1726185600 on 10999586. Therefore, it implies a Short% of Shares Outstanding of 11565005 and a Short% of Float of 7.95.

Most Popular